|
|
||||||||
Ann Thorac Surg 2003;75:453-456
© 2003 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, University of Innsbruck, Innsbruck, Austria
b Department of Cardiology, University of Innsbruck, Innsbruck, Austria
c Department of Microbiology, University of Innsbruck, Innsbruck, Austria
Accepted for publication July 10, 2002.
* Address reprint requests to Dr Müller, Department of Cardiac Surgery, University Hospital Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
e-mail: ludwig.mueller{at}uibk.ac.at
| Abstract |
|---|
|
|
|---|
METHODS: Owing to its features, which are comparable to those of homografts, the Freestyle aortic root xenograft was used in 10 consecutive patients aged between 32 and 77 years. All patients had extensive abscess formation, 5 presented with prosthetic valve endocarditis, 2 had additional mitral valve endocarditis requiring partial leaflet resection and reconstruction, 1 patient had an additional fistula into the right atrium, and 1 required coronary bypass. One patient developed a septic ventricular septal defect and fistula into the right atrium with tricuspid valve endocarditis.
RESULTS: None of the patients required reoperation for bleeding. Two (20%) patients died in the postoperative period, 1 due to multiorgan failure, and 1 due to preexisting invasive pulmonary aspergillosis. At autopsy, neither had evidence of intrapericardial hematoma or suture dehiscence. One patient died 13 months postoperatively without clinical signs of valve dysfunction or recurrent endocarditis. All other patients are well at 12 to 42 months after surgery. Clinical examination and echocardiography at the most recent follow-up showed no signs of valve dysfunction, recurrent fistulation, or endocarditis.
CONCLUSIONS: The Freestyle aortic root appears to be an acceptable alternative to homografts in the treatment of severe endocarditis. Long-term valve durability in younger patients, however, remains to be determined.
| Introduction |
|---|
|
|
|---|
Homografts are usually recommended because of their pliability and flexibility, which helps to create tension-free suture lines and fill abscess cavities with homograft tissue, as well as their resistance to infection. Xenograft aortic root prostheses may provide an alternative to homografts, which are of limited availability. We report our experience with xenograft reconstruction of the aortic root and the left ventricular outflow tract using theFreestyle Aortic Root Bioprosthesis (Medtronic, Inc., Minneapolis, MN) in patients with severe destructive endocarditis.
| Patients and methods |
|---|
|
|
|---|
|
Preoperative condition
Four patients were in acute heart failure; 1 of them was intubated and required mechanical ventilation due to severe pulmonary edema. Complete heart block was seen in 2 patients.
Intraoperative findings
All patients presented with acute necrotizing endocarditis with valvular vegetations and partial or total destruction of the annulus; 4 had additional subvalvular abscess formation. One patient had septic destruction of the membranous portion of the intraventricular septum, and in 1 perforation of the interatrial septum was noted. Three patients had fistulation from the aorta into the right atrium with perforation into the pericardial cavity in 1 of them. In 3 patients, additional severe (grade III or IV) mitral valve regurgitation was found, which was due to acute mitral valve endocarditis in 2 of them. One patient had tricuspid valve endocarditis.
Surgical treatment
All patients were put on mild to moderate hypothermic cardiopulmonary bypass using bicaval and ascending aortic cannulation. Myocardial protection was accomplished by retrograde (coronary sinus) and, if feasible, antegrade (by intubation of the coronary ostia) blood cardioplegia and topical cooling. Bypass times ranged from 203 to 381 minutes, and cross-clamping between 135 and 278 minutes. In 1 patient, hypothermic circulatory arrest for 26 minutes was required due to dissection of the ascending aorta.
After aortic cross-clamping, complete transection of the aorta was performed. After preliminary evaluation of the extent and severity of the disease, radical resection of all infected and necrotic tissue was performed without taking the extent of the created defect and later reconstruction or heart block into consideration. Typically, the full extent of the destructive process became evident only after radical debridement. Specimens of the valve and necrotic material were sent for bacteriological and histopathological investigation.
In all cases, reconstruction of the left ventricular outflow tract and the aortic root was accomplished by means of a Freestyle xenograft aortic root ranging from size 21 to 27 (median 23) as seen in Table 2. As the aortic annulus was invariably destroyed by the inflammatory process, full root replacement with reimplantation of the coronary ostia using the button technique had to be performed. The graft was sutured to the left ventricular outflow tract with either interrupted 40 polypropylene (Prolene), Teflon-coated polyester (Tevtek) sutures, or 40 polypropylene running sutures depending on the surgeons preference. Interrupted sutures were usually tied over a strip of pericardium to prevent leakage. 50 Prolene running sutures were used for implantation of the coronary ostia. The distal anastomosis between the xenograft and the ascending aorta was performed using a 40 Prolene running suture, which in all but the initial cases was buttressed by a strip of pericardium to prevent bleeding from the xenograft.
|
All patients were treated with appropriate antibiotic therapy according to the antibiogram (if a positive culture was obtained from blood or valve tissue) for at least 6 weeks postoperatively. In patients who received empirical antibiotic therapy before blood cultures were obtained (usually a second- or third-generation cephalosporin and aminoglycoside), the regimen was continued in the first 2 postoperative weeks and then changed to oral cephalosporins.
Microbiology
In 2 patients, blood cultures were positive for Staphylococcus aureus (see Table 1), which was resistant to methicillin in one of them. Coagulase-negative staphylococci were found in 2 patients and streptococci in 1. In another patient who had undergone repeated renal transplantation, Aspergillus fumigatus was demonstrated on the aortic valve. In 5 patients, bacterial cultures were negative because they were given empirical antibiotic therapy at the onset of fever before blood cultures had been obtained.
| Results |
|---|
|
|
|---|
The second patient was a 49-year-old woman with three failed renal transplants, abdominal sepsis, and invasive pulmonary aspergillosis. She died from sepsis on postoperative day 5. Postmortem examination in the 2 patients showed no signs of suture dehiscence or undue intrapericardial hematoma secondary to aortic root replacement.
One 31-year-old male patient died 13 months after surgery in his sleep. After aortic root replacement, he had a dual-chamber pacemaker inserted for complete atrioventricular block and was well at follow-up examination 2 weeks before death. Postmortem examination was not performed.
Survival of the remaining patients is listed in Table 2. All surviving patients are currently well in NYHA classes I (5) or II (2), with no signs of valve dysfunction or recurrent intracardiac defects on clinical and transthoracic echocardiographic follow-up.
| Comment |
|---|
|
|
|---|
Discussions about the optimum modality for reconstruction are still continuing. Because of their good results, some authors advocate reconstruction with autologous or bovine pericardium and insertion of a mechanical prosthesis in younger patients or a stented bioprosthesis in older ones [24], whereas others recommend the use of homografts, which in their experience, yield better results, provide technical advantages, and are more resistant to bacterial infection [5, 6, 8, 9] or even an autograft operation [5].
As a suitable homograft is often not available in such urgent cases, we decided to use xenografts because they are similar in terms of performance and surgical handling [10], and possibly also with respect to long-term results [11, 12]. On account of our good initial results, we now prefer the use of xenografts over homografts for this indication. The Freestyle aortic root bioprosthesis is a complete porcine aortic root with ligated coronary arteries, which is fixed in glutaraldehyde and treated with alpha-amino oleic acid to preclude calcification. It is less flexible and pliable than fresh or cryopreserved homografts, and little is known about its resistance to infection in active endocarditis. However, in a 5-year analysis of 95 patients, no reoperations for prosthetic valve endocarditis were necessary [3], and freedom from endocarditis was reported in 98% of patients at 5 years in a 21-center Food and Drug Administration clinical trial including 1,100 patients [13].
There were no significant technical problems resulting from a lack of pliability, and no major problems due to bleeding were encountered at the proximal or distal suture lines or at the reimplantation sites of the coronary ostia. Except for the initial cases autologous pericardium was employed to buttress the suture line at the anastomosis with the aorta to avoid bleeding from the suture tracts in the xenograft. None of our patients required reoperation; postmortem studies in 2 patients revealed no hematoma or other signs of technical problems. So far, the mortality rate in our series (20%) is in the expected range [4] and must be related to the extremely poor prognosis of the 2 patients who died in the perioperative period. Yet to date, no significant series of patients with other conduits has been reported in the literature where there has been freedom from reoperations for bleeding as well as freedom from recurrent endocarditis in all cases.
So far, only a few cases have been reported where the Freestyle bioprosthesis was used for endocarditis of comparable severity. In 3 patients with partial or complete discontinuity of the aortoventricular junction, a modified subcoronary implantation technique of the xenograft was described [14]. All patients survived with no signs of recurrent infection at 6 months of follow-up. Sakaguchi and associates [15] also used a subcoronary implantation technique in 1 patient with prosthetic valve endocarditis and abscess formation. Up to now, there has been a single report on full aortic root replacement using the Freestyle bioprosthesis for the same indication in 2 patients with favorable outcomes [16].
On account of the excellent surgical results in our series and the freedom from recurrent endocarditis in all survivors for up to 42 months postoperatively, we recommend the use of the Freestyle stentless bioprosthesis for this indication primarily in patients older than 60 years. In emergency settings and if a suitable homograft is not available, it seems to be a viable treatment option in younger patients as well.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. John, B. Al-Hariri, J. Ackemann, M. El-Mehsen, S. Roethemeyer, and H. Warnecke Subcoronary Implantation of a Stentless Valve in Patients with Aortic Aneurysms Asian Cardiovasc Thorac Ann, October 1, 2008; 16(5): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okada, H. Tanaka, H. Takahashi, N. Morimoto, H. Munakata, M. Asano, M. Matsumori, Y. Kawanishi, K. Nakagiri, and Y. Okita Aortic Root Replacement for Destructive Aortic Valve Endocarditis with Left Ventricular-Aortic Discontinuity Ann. Thorac. Surg., March 1, 2008; 85(3): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ngatchou, C. Stefanidis, A. S.E. Ramadan, and D. De Canniere Recurrent endocarditis of a bicuspid aortic valve due to Q fever Interactive CardioVascular and Thoracic Surgery, December 1, 2007; 6(6): 815 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mahesh, G. Angelini, M. Caputo, X. Y. Jin, and A. Bryan Prosthetic Valve Endocarditis Ann. Thorac. Surg., September 1, 2005; 80(3): 1151 - 1158. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |